Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity.

The stability of the human immunodeficiency virus type 1 (HIV-1) strain IIIB in drug solutions was studied. The data demonstrate that HIV-1 infectivity can be retained in drug solutions (e.g.